InSeal Medical

Company Overview

Snapshot

Founded in January 2008 by Avi Penner, InSeal Medical operates with over 12,000 employees. The company received CE Mark approval for its InClosure Large Bore Vascular Closure Device in August 2016.

Business overview

InSeal Medical develops and manufactures percutaneous vascular closure devices designed to seal puncture sites after treatments involving large-bore sheaths. Its primary product, the InSeal vascular closure device (VCD), supports the closure of 14 to 21 Fr punctures in vessels ranging from 6 to 10 millimeters in diameter. The device, made of a self-expandable nitinol frame covered with a biodegradable membrane, is delivered using the same sheath as the large-bore procedure. InSeal Medical serves the healthcare industry, specifically targeting providers in the medical devices and medical treatment & therapeutics sectors.

Strategic signal

In August 2016, InSeal Medical Ltd. announced CE Mark approval for its InClosure Large Bore Vascular Closure Device. This approval was a significant regulatory milestone, validating the device's compliance with European health, safety, and environmental protection standards, and signaling its readiness for market entry and broader adoption within the European medical community.

Company Intelligence Q&A

What is InSeal Medical's primary product?

InSeal Medical's primary product is the InSeal vascular closure device (VCD), which is designed to seal puncture sites following large-bore sheath procedures.

When was InSeal Medical founded?

InSeal Medical was founded in January 2008.

Who founded InSeal Medical?

InSeal Medical was founded by Avi Penner.

What was a key regulatory achievement for InSeal Medical?

In August 2016, InSeal Medical Ltd. announced CE Mark approval for its InClosure Large Bore Vascular Closure Device.

What is the status of InSeal Medical?

InSeal Medical is Non Active, having ceased to operate in December 2019.